miércoles, 1 de junio de 2016

New Drug for Bladder Cancer: Atezolizumab - National Cancer Institute

Atezolizumab - National Cancer Institute

National Cancer Institute

National Cancer Institute


  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
This page contains brief information about atezolizumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
FDA Approved

Use in Cancer

Atezolizumab is approved to treat:
Atezolizumab is also being studied in the treatment of other types of cancer.

More About Atezolizumab

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trials Accepting Patients

Find Clinical Trials for Atezolizumab - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: May 20, 2016
  • Updated: May 20, 2016
Atezolizumab - National Cancer Institute

No hay comentarios:

Publicar un comentario